RU-58841 Adhibitus ad Praeventionem Calvitiae et Calvitii Masculini
Detalia Producti
| Nomen | RU-58841 |
| Numerus CAS | 154992-24-2 |
| Formula molecularis | C17H18F3N3O3 |
| Pondus moleculare | 369.34 |
| Numerus EINECS | 1592732-453-0 |
| Punctum Ebullitionis | 493.6±55.0°C (Praedictum) |
| Densitas | 1.39 |
| Conditio repositionis | Signatum in sicco, in armario frigorifico servandum, sub -20°C. |
| Forma | Pulvis |
| Color | Albus |
| Sarcinatio | Saccus PE + saccus aluminii |
Synonyma
RU58841; 4-(4,4-Dimethyl-2,5-dioxo-3-(4-hydroxybutyl)1-imidazolidinyl)-2-(trifluoromethyl)benzonitrilum; 4-[3-(4-Hydroxybutyl)-4,4-dimethyl-2,5-dioxo-1-imidazolidinyl]-2-(trifluoromethyl)benzonitrilum; 4-[3-(4-Hydroxybutyl)-4,4-diMethyl-2,5-dioxoiMidazolidin-1-yl]-2-(trifluoromethyl)benzonitrilum; RU-58841E: candyli(apud)speedgainpharma(punctum)com; CS-637; RU588841; RU58841; RU58841; RU-58841
Effectus Pharmacologicus
Descriptio
RU 58841 (PSK-3841) est antagonista receptoris androgeni qui incrementum capillorum promovet.RU58841 est medicamentum experimentale ad curationem alopeciae androgenicae, quae etiam calvitium masculinum (MPD) appellatur, creatum.
Ut antiandrogenum topicum, principium actionis eius non idem est ac finasteridum. Finasteridum directe agit in 5α reductase, conversionem testosteroni in DHT inhibet, et DHT quantitatem in corpore minuit. RU58841 contactum inter dihydrotestosteronum et receptoria folliculorum pili inhibet, non directe quantitatem DHT minuit, sed nexum DHT et receptoriorum folliculorum pili minuit, ut finem curationis alopeciae androgeneticae consequatur.
4-[3-(4-Hydroxybutyl)-4,4-dimethyl-2,5-dioxo-1-imidazolidinyl]-2-(trifluoromethyl)benzonitrilum ut medicamentum intermediarium synthesis chemicae adhiberi potest.Si 4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxo-1-imidazolidinyl]-2-(trifluoromethyl)benzonitrilum inhalatur, aegrotum ad aerem purum move;Si cutis attingatur, vestes contaminatas remove, cutem aqua et sapone diligenter ablue, et si molestia oritur, medicum pete;
Effectus Secundarius
RU58841 cuti capitis applicatur, a folliculis pili absorbetur, et theoretice, in sanguinem ingredi et alias corporis partes afficere potest. Sed nulli effectus secundarii systemici in studiis applicationis topicae in simiis inventi sunt. Nihilominus, quidam qui RU58841 experti sunt affirmant se quosdam effectus secundarios ex usu RU expertos esse, inter quos irritatio cutis, libido imminuta, dysfunctio erectilis, nausea, oculi rubri, vertigo, et dolor capitis.
